KCT0007590
Recruiting
未知
A Noninterventional Exit Survey Study to Understand Meaningful Change in Subjects with Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma who Discontinued Treatment in the SPOTLIGHT or GLOW Study
Astellas Korea0 sites14 target enrollmentTBD
ConditionsNeoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Neoplasms
- Sponsor
- Astellas Korea
- Enrollment
- 14
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written informed consent and privacy language as per national regulations (e.g., HIPAA Authorization for US sites) must be obtained from the subject or legally authorized representative (if applicable) prior to any study\-related procedures.
- •2\. Subjects who are within 30 days following the treatment discontinuation visit(s) (both study treatments) in the SPOTLIGHT (8951\-CL\-0301\) or GLOW (8951\-CL\-0302\) study.
Exclusion Criteria
- •1\. Subject has any concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study, which places the subject at undue risk or complicates the interpretation of data in the opinion of the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A prospective non-interventional study to evaluate the effect of Triptorelin Embonate (Diphereline (Trademark TM) 11.25mg) on lower urinary tract symptoms (LUTS) in Australian prostate cancer patients.ocally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Locally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Cancer - ProstateRenal and Urogenital - Other renal and urogenital disordersACTRN12610000558022Ipsen Pty Ltd70
Completed
Not Applicable
CAPTURE-IOType 2 Diabetes MellitusJPRN-jRCT1080224506ovo Nordisk Pharma Ltd.8,000
Not yet recruiting
Not Applicable
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritisDRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40
Not yet recruiting
Not Applicable
Is variations in sleep pattern responsible for Aamavata(Rheumatoid Arthritis)Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecifiedCTRI/2021/02/030960All India Institute of Ayurveda
Completed
Not Applicable
A non-interventional, post-marketing survey study of healthcare professionals based on their experience using a high-fiber enteral feeding.ConstipationJPRN-UMIN000048410estle Health Science Company, Nestle Japan Ltd.184